1. Home
  2. HAIN vs EDSA Comparison

HAIN vs EDSA Comparison

Compare HAIN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.50

Market Cap

53.7M

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$4.97

Market Cap

56.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAIN
EDSA
Founded
1993
2015
Country
United States
Canada
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.7M
56.1M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
HAIN
EDSA
Price
$0.50
$4.97
Analyst Decision
Hold
Strong Buy
Analyst Count
9
1
Target Price
$2.23
$5.00
AVG Volume (30 Days)
789.8K
59.3K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,457,769,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.72
52 Week High
$1.95
$20.32

Technical Indicators

Market Signals
Indicator
HAIN
EDSA
Relative Strength Index (RSI) 37.40 32.29
Support Level N/A $4.87
Resistance Level $0.61 $6.58
Average True Range (ATR) 0.04 0.52
MACD -0.00 -0.13
Stochastic Oscillator 9.70 9.85

Price Performance

Historical Comparison
HAIN
EDSA

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: